Barely Significant
← all excerpts

Identification of CD105 (endoglin) as novel risk marker in CLL.

Ann Hematol · 2022 · PMC8913466 · PMID 35044512

Europe PMCDOI
1
hedged sentence
0.1500
closest p · 3.0× alpha
0.1500
boldest claim

The sentences

failed to reach statistical significancep = 0.15not close (p > 0.1)
A tendency to higher CD105 levels was observed for Rai stages I–II versus Rai stage 0, but failed to reach statistical significance ( p = 0.15).

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.